David R. Corey
E1292057
UNEXPLORED
David R. Corey is a biotechnology entrepreneur best known as a co-founder of Alnylam Pharmaceuticals, a pioneering company in RNA interference–based therapeutics.
All labels observed (1)
| Label | Occurrences |
|---|---|
| David R. Corey canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T17871410 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: David R. Corey Context triple: [Alnylam Pharmaceuticals, Inc., foundedBy, David R. Corey]
-
A.
Michael V. Drake
Michael V. Drake is an American academic leader and physician who has served as president of both The Ohio State University and the University of California system.
-
B.
Stephen M. Kellen
Stephen M. Kellen was a prominent financier and philanthropist known for his leadership at Arnhold and S. Bleichroeder and his significant support of cultural and educational institutions.
-
C.
Brett M. Reed
Brett M. Reed is a film editor best known for his work on the 2010 action movie "The Expendables."
-
D.
David Reiman
David Reiman is a researcher who contributed as a co-author to the landmark 2021 Nature paper by Jumper et al. describing the AlphaFold protein structure prediction system.
-
E.
Christopher B. Duncan
Christopher B. Duncan is an American actor best known for his comedic television roles, including portrayals of presidential and authority figures.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: David R. Corey Target entity description: David R. Corey is a biotechnology entrepreneur best known as a co-founder of Alnylam Pharmaceuticals, a pioneering company in RNA interference–based therapeutics.
-
A.
Michael V. Drake
Michael V. Drake is an American academic leader and physician who has served as president of both The Ohio State University and the University of California system.
-
B.
Stephen M. Kellen
Stephen M. Kellen was a prominent financier and philanthropist known for his leadership at Arnhold and S. Bleichroeder and his significant support of cultural and educational institutions.
-
C.
Brett M. Reed
Brett M. Reed is a film editor best known for his work on the 2010 action movie "The Expendables."
-
D.
David Reiman
David Reiman is a researcher who contributed as a co-author to the landmark 2021 Nature paper by Jumper et al. describing the AlphaFold protein structure prediction system.
-
E.
Christopher B. Duncan
Christopher B. Duncan is an American actor best known for his comedic television roles, including portrayals of presidential and authority figures.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.